• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

PNHP

  • Home
  • Contact PNHP
  • Join PNHP
  • Donate
  • PNHP Store
  • About PNHP
    • Mission Statement
    • Local Chapters
    • Student chapters
    • Board of Directors
    • National Office Staff
    • Contact Us
    • Privacy Policy
  • About Single Payer
    • What is Single Payer?
    • How do we pay for it?
    • History of Health Reform
    • Conservative Case for Single Payer
    • FAQs
    • Información en EspaƱol
  • Take Action
    • The Medicare for All Act of 2025
    • Moral Injury and Distress
    • Medical Society Resolutions
    • Recruit Colleagues
    • Schedule a Grand Rounds
    • Letters to the Editor
    • Lobby Visits
  • Latest News
    • Sign up for e-alerts
    • Members in the news
    • Health Justice Monitor
    • Articles of Interest
    • Latest Research
    • For the Press
  • Reports & Proposals
    • Physicians’ Proposal
    • Medicare Advantage Equity Report
    • Medicaid Managed Care Report
    • Medicare Advantage Harms Report
    • Medicare Advantage Overpayments Report
    • Pharma Proposal
    • Kitchen Table Campaign
    • COVID-19 Response
  • Member Resources
    • 2025 Annual Meeting Materials
    • Member Interest Groups (MIGs)
    • Speakers Bureau
    • Slideshows
    • Newsletter
    • Materials & Handouts
    • Webinars
    • Host a Screening
    • Events Calendar
    • Join or renew your membership

The official blog of PNHP

PNHP pharma reform proposal in the news

Healing an ailing pharmaceutical system highlights the need for fundamental reform

Healing an Ailing Pharmaceutical System: Prescription for Reform in the United States and Canada was unveiled May 17, 2018 at the National Press Club in Washington, D.C. (To read the full proposal, click here. To read PNHP’s press release on the proposal, click here.) Please see below for a sampling of the substantial media coverage related to the proposal.

***

Video summary

***

Introductory press conference

***

Webinar by Dr. Adam Gaffney

***

News coverage

How to fix the American drug industry
By Ryan Cooper
The Week, May 17, 2018
In America, medication is extremely expensive — and it’s getting worse. Stories of Wall Street bloodsuckers snatching up the patent on some lifesaving drug and jacking up the price by many thousands of percent are routine Continue reading…

Doctors in Canada and US call for ā€˜fundamental reform’ on prescription drug prices

By Cherise Seucharan
The Toronto Star, May 17, 2018
A new report written by doctors in Canada and the U.S. is calling for major reforms to lower the price of drugs. Published in the British Medical Journal, the report is the result of a two year-study by the U.S./Canadian Pharmaceutical Policy Reform Working Group. Continue reading…

US doctors propose universal health care to fix ā€˜dysfunctional’ system
By Ellen Daniel
Pharmaceutical Technology News, May 17, 2018
A group of 21 doctors from the US and Canada has published a proposal aimed at ensuring access to ā€˜safe, innovative, and affordable’ medications. Continue reading…

Rebuking Industry-Friendly Trump Plan, Doctors Offer Blueprint to Confront ‘Greed of Big Pharma’
By Jake Johnson
Common Dreams, May 17, 2018
After President Donald Trump conclusively demonstrated last week that he is unwilling to take on the pharmaceutical industry and has no “legitimate plan” to lower drug prices, a group of 21 American and Canadian doctors on Thursday unveiled an ambitious plan. Continue reading…

Can an Obscure, 100-Year-Old Patent Law Take On Big Pharma?
By Jacquie Lee
Bloomberg, May 21 2018
Proposed solutions for lowering drug prices typically hinge on sweeping transformations within the drug-supply chain, but what if there’s a more immediate solution? There is, according to Sidney Wolfe, founder of Public Citizen’s health research group. Continue reading…

***

Opinion pieces

Trump’s plan won’t lower prescription drug prices. Ours would.
By Adam Gaffney, M.D.
Washington Post, May 23, 2018
The drug price reforms that President Trump recently proposed are as potent as a placebo, but not as harmless. Trump once blustered that drug firms were ā€œgetting away with murder,ā€ but his real-life plan caused pharmaceutical stocks to surge. Continue reading…

No, raising drug prices in Canada will not help the U.S.
By Joel Lexchin
National Post (Toronto), May 18, 2018
Donald Trump’s solution to soaring American drug prices is to have other countries, such as Canada, raise their prices. This is not a new position; American officials have been advocating this approach for at least the past 15 years. Continue reading…

Only a healthy democracy will save us from Big Pharma
By Ed Weisbart, M.D.
St. Louis Post-Dispatch, June 8, 2018
I’m a physician who volunteers in safety-net clinics in St. Louis, constantly seeing patients who can’t afford the medicines I prescribe. Even patients with insurance often can’t afford their co-pays and deductibles, and many treatments simply aren’t covered by their plans. Continue reading…

Healing an ailing pharmaceutical system: economic analysis and supplemental materials

Physicians for a National Health Program and Canadian Doctors for Medicare have joined forces to develop a landmark proposal, “Healing an Ailing Pharmaceutical System: Prescription for Reform in the United States and Canada.” Below, please find an economic analysis and supplemental materials related to the proposal. To read media coverage of the proposal, click here. You may also wish to read and/or distribute our one-page handout, which includes a useful summary of the proposal.

Table 7

One-page handout: Healing an ailing pharmaceutical system

Slideshow: Prescription for Pharmaceutical Reform by Ed Weisbart, M.D.

Table 1: Examples of problems in drug access and pricing in the US and Canada

Table 2: Global evidence of lagging innovation in the drug development process

Table 3: Examples of problems in industry-sponsored clinical trial design

Table 4: Examples of problems in drug approval and regulation

Table 5: Examples of problems in postmarketing surveillance of drugs

Table 6: Examples of problems in drug promotion

Table 7: Estimated effects of proposed reforms on U.S. national pharmaceutical expenditures, 2017 (includes methodology)

Tables 1-7: References

A more accessible video on the BUSPH symposium on Trump and public health

Healing an ailing pharmaceutical system: prescription for reform for U.S. and Canada

Health Industry CEOs’ Compensation in 2017

Policy Details

Chapters

2018 SNaHP Summit Materials

Why We Need Permanent Security Clearances For Candidates For the White House

Trump’s Medicaid: Sabotage of a Five-Decade Social Contract

Corporate Mergers of Health Care Giants: CEOs and Wall Street Win, Patients Lose

2017 Annual Meeting Materials

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Interim pages omitted …
  • Page 50
  • Go to Next Page »

Primary Sidebar

  • About PNHP
    • Mission Statement
    • Local Chapters
    • Student chapters
    • Board of Directors
    • National Office Staff
    • Contact Us
    • Privacy Policy
  • About Single Payer
    • What is Single Payer?
    • How do we pay for it?
    • History of Health Reform
    • Conservative Case for Single Payer
    • FAQs
    • Información en EspaƱol
  • Take Action
    • The Medicare for All Act of 2025
    • Moral Injury and Distress
    • Medical Society Resolutions
    • Recruit Colleagues
    • Schedule a Grand Rounds
    • Letters to the Editor
    • Lobby Visits
  • Latest News
    • Sign up for e-alerts
    • Members in the news
    • Health Justice Monitor
    • Articles of Interest
    • Latest Research
    • For the Press
  • Reports & Proposals
    • Physicians’ Proposal
    • Medicare Advantage Equity Report
    • Medicaid Managed Care Report
    • Medicare Advantage Harms Report
    • Medicare Advantage Overpayments Report
    • Pharma Proposal
    • Kitchen Table Campaign
    • COVID-19 Response
  • Member Resources
    • 2025 Annual Meeting Materials
    • Member Interest Groups (MIGs)
    • Speakers Bureau
    • Slideshows
    • Newsletter
    • Materials & Handouts
    • Webinars
    • Host a Screening
    • Events Calendar
    • Join or renew your membership

Footer

  • About PNHP
    • Mission Statement
    • Local Chapters
    • Student chapters
    • Board of Directors
    • National Office Staff
    • Contact Us
    • Privacy Policy
  • About Single Payer
    • What is Single Payer?
    • How do we pay for it?
    • History of Health Reform
    • Conservative Case for Single Payer
    • FAQs
    • Información en EspaƱol
  • Take Action
    • The Medicare for All Act of 2025
    • Moral Injury and Distress
    • Medical Society Resolutions
    • Recruit Colleagues
    • Schedule a Grand Rounds
    • Letters to the Editor
    • Lobby Visits
  • Latest News
    • Sign up for e-alerts
    • Members in the news
    • Health Justice Monitor
    • Articles of Interest
    • Latest Research
    • For the Press
  • Reports & Proposals
    • Physicians’ Proposal
    • Medicare Advantage Equity Report
    • Medicaid Managed Care Report
    • Medicare Advantage Harms Report
    • Medicare Advantage Overpayments Report
    • Pharma Proposal
    • Kitchen Table Campaign
    • COVID-19 Response
  • Member Resources
    • 2025 Annual Meeting Materials
    • Member Interest Groups (MIGs)
    • Speakers Bureau
    • Slideshows
    • Newsletter
    • Materials & Handouts
    • Webinars
    • Host a Screening
    • Events Calendar
    • Join or renew your membership
©2026 PNHP